{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:28:40Z","timestamp":1787696920030,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T00:00:00Z","timestamp":1395187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s10461-014-0751-x","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T16:18:14Z","timestamp":1395159494000},"page":"811-819","source":"Crossref","is-referenced-by-count":23,"title":["Adherence in the CAPRISA 004 Tenofovir Gel Microbicide Trial"],"prefix":"10.1007","volume":"18","author":[{"given":"Leila Essop","family":"Mansoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quarraisha","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonhlanhla","family":"Yende-Zuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"MacQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette T.","family":"Madlala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Grobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,19]]},"reference":[{"key":"751_CR1","unstructured":"UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2012. Available from: Global report: UNAIDS report on the global AIDS epidemic 2012. Geneva: Joint United Nations Programme on HIV\/AIDS2012. Accessed 25 Mar 2013."},{"issue":"9338","key":"751_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","volume":"360","author":"L Damme Van","year":"2002","unstructured":"Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360(9338):971\u20137.","journal-title":"Lancet"},{"key":"751_CR3","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1371\/journal.pone.0001474","volume":"3","author":"PJ Feldblum","year":"2008","unstructured":"Feldblum PJ, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One. 2008;3:e1474.","journal-title":"PLoS One"},{"issue":"12","key":"751_CR4","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1371\/journal.pone.0001312","volume":"2","author":"L Peterson","year":"2007","unstructured":"Peterson L, Nanda K, Opoku BK, et al. SAVVY(R) (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One. 2007;2(12):e1312.","journal-title":"PLoS One"},{"issue":"9654","key":"751_CR5","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","volume":"372","author":"S Skoler-Karpoff","year":"2008","unstructured":"Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977\u201387.","journal-title":"Lancet"},{"key":"751_CR6","doi-asserted-by":"crossref","first-page":"e3784","DOI":"10.1371\/journal.pone.0003784","volume":"3","author":"V Halpern","year":"2008","unstructured":"Halpern V, Ogunsola F, Obunge O, et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a phase III trial in Nigeria. PLoS One. 2008;3:e3784.","journal-title":"PLoS One"},{"key":"751_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","volume":"359","author":"L Damme Van","year":"2008","unstructured":"Van Damme L, Govinden R, Mirembe FM, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med. 2008;359:463\u201372.","journal-title":"N Engl J Med"},{"key":"751_CR8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168\u201374.","journal-title":"Science"},{"key":"751_CR9","doi-asserted-by":"crossref","unstructured":"Tolley EE, Harrison PF, Goetghebeur E, et al. Adherence and its measurement in phase 2\/3 microbicide trials. AIDS Behav. 2010;14(5):1124\u201336.","DOI":"10.1007\/s10461-009-9635-x"},{"key":"751_CR10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Damme Van","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411\u201322.","journal-title":"N Engl J Med"},{"key":"751_CR11","unstructured":"Marrazzo J, Ramjee G, Nair G, et al., editors. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir\/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003). Conference of Retroviral and Opportunistic Infections; 2013. Goergia World Congress Centre, Atlanta."},{"issue":"11","key":"751_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1258\/0956462042395195","volume":"15","author":"SE Reid","year":"2004","unstructured":"Reid SE, Reid CA, Vermund SH. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. Int J STD AIDS. 2004;15(11):713\u20136.","journal-title":"Int J STD AIDS"},{"key":"751_CR13","volume-title":"Methodological challenges in biomedical HIV prevention trials","year":"2008","unstructured":"Lagakos S, Gable A, editors. Methodological challenges in biomedical HIV prevention trials. Washington, DC: National Academies Press; 2008."},{"key":"751_CR14","volume-title":"Investigators Brochure: tenofovir gel (GS-1278)","author":"Gilead Sciences Inc","year":"2013","unstructured":"Gilead Sciences Inc. Investigators Brochure: tenofovir gel (GS-1278). 5th ed. Foster City: California Gilead Sciences; 2013.","edition":"5"},{"issue":"4","key":"751_CR15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.aids.0000210608.70762.c3","volume":"20","author":"KH Mayer","year":"2006","unstructured":"Mayer KH, Maslankowski LA, Gai F, et al. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006;20(4):543\u201351.","journal-title":"AIDS"},{"issue":"7158","key":"751_CR16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/449024c","volume":"449","author":"SS Abdool Karim","year":"2007","unstructured":"Abdool Karim SS, Abdool Karim Q. Diverse approaches useful for microbicide trials. Nature. 2007;449(7158):24.","journal-title":"Nature"},{"issue":"4","key":"751_CR17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1037\/0278-6133.25.4.462","volume":"25","author":"JD Fisher","year":"2006","unstructured":"Fisher JD, Fisher WA, Rivet Amico K, et al. An information\u2013motivation\u2013behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462\u201373.","journal-title":"Health Psychol"},{"key":"751_CR18","first-page":"40","volume-title":"Emerging theories in health promotion practice and research","author":"JD Fisher","year":"2002","unstructured":"Fisher JD, Fisher WA. The information\u2013motivation\u2013behavioural skills model. In: DiClemente RJ, Crosby RA, Kegler MC, editors. Emerging theories in health promotion practice and research. Jossey-Bass: San Francisco; 2002. p. 40\u201370."},{"key":"751_CR19","first-page":"775","volume":"33","author":"S Misovich","year":"2003","unstructured":"Misovich S, Fisher J, Martinez T, et al. Predicting breast self-examination: a test of the information\u2013motivation\u2013behavioural skills model. J Appl Psychol. 2003;33:775.","journal-title":"J Appl Psychol"},{"key":"751_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1037\/1089-2680.1.1.72","volume":"1","author":"S Misovich","year":"1997","unstructured":"Misovich S, Fisher J, Fisher W. Close relationships and HIV risk behaviour: evidence and possible underlying psychological processes. Gen Psychol Rev. 1997;1:72\u2013107.","journal-title":"Gen Psychol Rev"},{"issue":"2","key":"751_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1022423417304","volume":"33","author":"MP Carey","year":"1997","unstructured":"Carey MP, Carey KB, Weinhardt LS, et al. Behavioral risk for HIV infection among adults with a severe and persistent mental illness: patterns and psychological antecedents. Community Ment Health J. 1997;33(2):133\u201342.","journal-title":"Community Ment Health J"},{"issue":"6","key":"751_CR22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/09540120500038058","volume":"17","author":"KR Amico","year":"2005","unstructured":"Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care. 2005;17(6):661\u201373.","journal-title":"AIDS Care"},{"issue":"Suppl 1","key":"751_CR23","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.qai.0000245887.58886.ac","volume":"43","author":"SB Mannheimer","year":"2006","unstructured":"Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S41\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"751_CR24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/09540121003623719","volume":"22","author":"RA Ferrer","year":"2010","unstructured":"Ferrer RA, Morrow KM, Fisher WA, et al. Toward an information\u2013motivation\u2013behavioral skills model of microbicide adherence in clinical trials. AIDS Care. 2010;22(8):997\u20131005.","journal-title":"AIDS Care"},{"issue":"Suppl 1","key":"751_CR25","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/01.qai.0000248335.90190.f9","volume":"43","author":"JD Fisher","year":"2006","unstructured":"Fisher JD, Cornman DH, Norton WE, et al. Involving behavioral scientists, health care providers, and HIV-infected patients as collaborators in theory-based HIV prevention and antiretroviral adherence interventions. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S10\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"751_CR26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S135246580001643X","volume":"23","author":"S Rollnick","year":"1995","unstructured":"Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother. 1995;23:325\u201334.","journal-title":"Behav Cogn Psychother"},{"issue":"1","key":"751_CR27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0749-3797(00)00254-3","volume":"20","author":"KM Emmons","year":"2001","unstructured":"Emmons KM, Rollnick S. Motivational interviewing in health care settings. Opportunities and limitations. Am J Prev Med. 2001;20(1):68\u201374.","journal-title":"Am J Prev Med"},{"key":"751_CR28","doi-asserted-by":"crossref","unstructured":"Mansoor LE, Abdool Karim Q, Werner L, et al. Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial. AIDS Behav. 2014. doi: 10.1007\/s10461-014-0752-9 .","DOI":"10.1007\/s10461-014-0752-9"},{"issue":"49","key":"751_CR29","first-page":"64","volume":"2008","author":"CK Mauck","year":"1999","unstructured":"Mauck CK, Van de Straten A. Using objective markers to assess participant behavior in HIV prevention trials of vaginal microbicides. J Acquir Immune Defic Syndr. 1999;2008(49):64\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"751_CR30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/OLQ.0b013e3181972397","volume":"36","author":"MN Austin","year":"2009","unstructured":"Austin MN, Rabe LK, Hillier SL. Limitations of the dye-based method for determining vaginal applicator use in microbicide trials. Sex Transm Dis. 2009;36(6):368\u201371.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"751_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.contraception.2006.10.012","volume":"76","author":"AR Wallace","year":"2007","unstructured":"Wallace AR, Teitelbaum A, Wan L, et al. Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials. Contraception. 2007;76(1):53\u20136.","journal-title":"Contraception"},{"key":"751_CR32","doi-asserted-by":"crossref","unstructured":"Mngadi KT, Maarschalk S, Grobler AC, et al. Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial. AIDS Behav. 2014. doi: 10.1007\/s10461-014-0696-0 .","DOI":"10.1007\/s10461-014-0696-0"},{"key":"751_CR33","doi-asserted-by":"crossref","first-page":"18505","DOI":"10.7448\/IAS.16.1.18505","volume":"16","author":"C Woodsong","year":"2013","unstructured":"Woodsong C, MacQueen K, Amico KR, et al. Microbicide clinical trial adherence: insights for introduction. J Int AIDS Soc. 2013;16:18505.","journal-title":"J Int AIDS Soc"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-014-0751-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-014-0751-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-014-0751-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T17:42:17Z","timestamp":1559151737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-014-0751-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,19]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1007\/s10461-014-0751-x","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,19]]}}}